introduction migraine ancient treatment functional pharmacology antimigraine therapy pubmed ncbi abstract migraine treatment evolved realms supernatural scientific arena controversial migraine primarily vascular neurological dysfunction irrespective controversy levels serotonin num hydroxytryptamine num ht vasoconstrictor central neurotransmitter decrease migraine carotid vasodilatation i v infusion num ht abort migraine fact num ht ergotamine dihydroergotamine antimigraine agents invariably produce vasoconstriction external carotid circulation decade witnessed advent sumatriptan generation triptans e g zolmitriptan rizatriptan naratriptan belong class drugs num ht num num num receptor agonists compared sumatriptan second-generation triptans higher oral bioavailability longer plasma half-life line vascular neurogenic theories migraine triptans produce selective carotid vasoconstriction num ht num receptors presynaptic inhibition trigeminovascular inflammatory responses implicated migraine num ht num num ht num receptors selective agonists num ht num pnu num num ht num ly num receptors inhibit trigeminovascular system producing vasoconstriction pnu num proved ineffective acute treatment migraine whilst ly num show efficacy doses interact num ht num receptors finally triptans effective antimigraine agents producing selective cranial vasoconstriction efforts made develop effective antimigraine alternatives acting direct blockade vasodilator mechanisms e g antagonists cgrp receptors antagonists num ht num receptors inhibitors nitric oxide biosynthesis alternatives lead fewer side-effects 
